Many Growth Opportunities Emerging in the U.S. Infectious Disease In-Vitro Diagnostics Market.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c50504) has announced the addition of Frost & Sullivan's new report: U.S. Infectious Disease Infectious disease A pathological condition spread among biological species. Infectious diseases, although varied in their effects, are always associated with viruses, bacteria, fungi, protozoa, multicellular parasites and aberrant proteins known as prions. Diagnostics Markets to their offering. This research service, titled U.S. Infectious Disease Diagnostics Markets, provides comprehensive analysis of market drivers, restraints, challenges, and trends. Moreover, analysis of market share, competitive structure, revenue forecasts, and products is included. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: molecular infectious disease diagnostics, immunoassay Immunoassay An assay that quantifies antigen or antibody by immunochemical means. The antigen can be a relatively simple substance such as a drug, or a complex one such as a protein or a virus. infectious disease diagnostics, and culture infectious disease diagnostics. Market Sectors Expert analysts thoroughly examine the following market sectors in this research: -- Molecular -- Immunoassay -- Culture Technologies The following technologies are covered in this research: -- PCR PCR polymerase chain reaction. PCR abbr. polymerase chain reaction Polymerase chain reaction (PCR) -- Automated antimicrobial susceptibility testing -- Molecular technologies and assays -- Immunoassays -- Microbiology culture methods Market Overview The U.S. infectious disease diagnostics market will play a significant role in the dynamic IVD (Interactive VideoDisc) See interactive video. market. This market is segmented according to molecular, immunoassays, and culture infectious disease products. Total market revenues for base year 2005 are $3,823.1 with a CAGR CAGR See: Compound Annual Growth Rate of 7.7%. The most substantial growth is expected in the molecular segment. The U.S. infectious disease diagnostics market is highly competitive and saturated. Tremendous growth opportunities exist in the U.S. infectious disease in-vitro diagnostics market. High growth areas include viral load testing, nosocomial infection Nosocomial infection An infection that can be acquired in a hospital. ABPA is a nosocomial infection. Mentioned in: Allergic Bronchopulmonary Aspergillosis, Hospital-Acquired Infections, Pseudomonas Infections screening, rapid influenza detection, and STD testing. Rapid detection and fast turn-around time (TAT) are able to lower total overall healthcare costs. Quick TAT is especially relevant to infectious disease testing, as fast diagnosis increases treatment options and patient prognosis. Technical superiority of molecular methods is phasing out other types or more traditional methods, such as culture based tests, which have TATs of only days and are labor intensive Labor Intensive A process or industry that requires large amounts of human effort to produce goods. Notes: A good example is the hospitality industry (hotels, restaurants, etc), they are considered to be very people-oriented. See also: Capital Intensive, Trading Dollars . For more information visit http://www.researchandmarkets.com/reports/c50504 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion